Contec Medical Systems (300869) Fundamentals 2026 — Revenue Analysis | SniperIQ
Contec Medical Systems (300869) is a CN-listed Healthcare company in Medical - Specialties with a market capitalization of ¥4.2B, trading at ¥10.56 on the SHZ. This SniperIQ fundamentals page covers Contec Medical Systems's valuation, profitability (net margin -10.8%), revenue (¥464M in FY2025), balance-sheet quality, and AI signal context — from live market data, research only.
Full research coverage
- 8-Quarter Revenue & Margin Trend
- Debt Maturity & Coverage
- Peer Valuation Comparison
- Free Cash Flow & Owner Earnings
- AI Signal + Institutional Flow
- DCF Valuation Model
Frequently Asked Questions
What is Contec Medical Systems's market cap?
Contec Medical Systems (300869) has a market capitalization of approximately ¥4.2B, trading at ¥10.56 on the SHZ. Market cap moves with the live share price.
What is Contec Medical Systems's P/E ratio?
Contec Medical Systems's trailing twelve-month P/E ratio is not meaningful (negative or nil earnings), with a price-to-book (P/B) of 2.5x. Valuation multiples are best compared with Healthcare sector peers rather than read in isolation.
How profitable is Contec Medical Systems?
Contec Medical Systems runs a net profit margin of -10.8%, a gross margin of 45.8%, and an operating margin of -10.5%. Margins and ROE indicate how efficiently the business converts sales into profit and shareholder returns.
How much revenue does Contec Medical Systems generate?
Contec Medical Systems reported revenue of ¥464M for fiscal year 2025, with net income of -¥24M and earnings per share (EPS) of -0.0608. SniperIQ tracks the full 8-quarter revenue and margin trend on the research dashboard.
Does Contec Medical Systems pay a dividend?
Contec Medical Systems does not currently show a material trailing dividend yield; it is positioned more as a total-return name. Always confirm the latest dividend policy in the company's filings.
Is Contec Medical Systems financially healthy?
Contec Medical Systems carries a debt-to-equity ratio of 0.57x and a current ratio of 7.80x, with a market beta of 0.08. Lower leverage and a current ratio above 1.0 generally signal a stronger balance sheet.
Is Contec Medical Systems a good stock to buy in 2026?
SniperIQ provides research-only market intelligence, not personalised financial advice or a buy/sell call. For Contec Medical Systems (300869) the key facts are: market cap ¥4.2B, revenue ¥464M, 52-week range 9.98-21.54. Weigh valuation, profitability, growth, and balance-sheet strength against Healthcare peers and form your own view.
Track Contec Medical Systems's full fundamentals live
Get Contec Medical Systems's 8-quarter revenue and margin trend, peer comparison, DCF model, and AI signal on the SniperIQ research dashboard.